Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-20
DOI
10.3389/fimmu.2018.02674
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need
- (2017) Andrew D. Cox et al. VACCINE
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
- (2016) Sydel R Parikh et al. LANCET
- Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women
- (2015) G. Kwatra et al. CLINICAL MICROBIOLOGY AND INFECTION
- Long-term Persistence of Immunity and B-Cell Memory Following Haemophilus influenzae Type b Conjugate Vaccination in Early Childhood and Response to Booster
- (2014) K. P. Perrett et al. CLINICAL INFECTIOUS DISEASES
- Review on the association of Group BStreptococcuscapsular antibody and protection against invasive disease in infants
- (2014) Ziyaad Dangor et al. Expert Review of Vaccines
- Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study
- (2014) Natalie G Martin et al. LANCET INFECTIOUS DISEASES
- Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
- (2014) Nick J Andrews et al. LANCET INFECTIOUS DISEASES
- Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy
- (2013) Nina Ekström et al. Clinical and Vaccine Immunology
- Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991–2010
- (2013) Theresa L. Lamagni et al. CLINICAL INFECTIOUS DISEASES
- Maternal Antibody at Delivery Protects Neonates From Early Onset Group B Streptococcal Disease
- (2013) C. J. Baker et al. JOURNAL OF INFECTIOUS DISEASES
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
- (2013) Ulrich Vogel et al. LANCET INFECTIOUS DISEASES
- Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants
- (2013) Shabir A. Madhi et al. VACCINE
- Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
- (2012) Patricia Kaaijk et al. BMC INFECTIOUS DISEASES
- Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines
- (2012) Morven S. Edwards et al. VACCINE
- Maintenance of Immune Response throughout Childhood following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood
- (2011) A. Khatami et al. Clinical and Vaccine Immunology
- Bacterial Meningitis in the United States, 1998–2007
- (2011) Michael C. Thigpen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months
- (2011) F.M. Russell et al. VACCINE
- Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults
- (2010) J. E. LORTAN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial
- (2010) K. P. Perrett et al. CLINICAL INFECTIOUS DISEASES
- Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease
- (2010) Sonia Davila et al. NATURE GENETICS
- The Fc Receptor IIA-R/R131 Genotype Is Associated with Severe Sepsis in Community-Acquired Pneumonia
- (2009) H. Endeman et al. Clinical and Vaccine Immunology
- Human Neutrophils Kill Streptococcus pneumoniae via Serine Proteases
- (2009) A. J. Standish et al. JOURNAL OF IMMUNOLOGY
- Investigation of serum bactericidal activity in childhood and adolescence 3–6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine
- (2009) Irine-Ikbale Sakou et al. VACCINE
- Vaccine-Induced Opsonophagocytic Immunity to Neisseria meningitidis Group B
- (2008) J. S. Plested et al. Clinical and Vaccine Immunology
- Impaired Opsonization with C3b and Phagocytosis of Streptococcus pneumoniae in Sera from Subjects with Defects in the Classical Complement Pathway
- (2008) J. Yuste et al. INFECTION AND IMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started